A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
Saved in:
| Title: | A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol. |
|---|---|
| Authors: | Fragoso-Saavedra, Sergio1,2 (AUTHOR), Iruegas-Nunez, David A.2,3 (AUTHOR), Quintero-Villegas, Alejandro4 (AUTHOR), García-González, H. Benjamín4 (AUTHOR), Nuñez, Isaac4 (AUTHOR), Carbajal-Morelos, Sergio L.4 (AUTHOR), Audelo-Cruz, Belem M.2 (AUTHOR), Arias-Martínez, Sarahi2 (AUTHOR), Caro-Vega, Yanink5 (AUTHOR), Calva, Juan José5 (AUTHOR), Luqueño-Martínez, Verónica5 (AUTHOR), González-Duarte, Alejandra2 (AUTHOR), Crabtree-Ramírez, Brenda5 (AUTHOR), Crispín, José C.6 (AUTHOR), Sierra-Madero, Juan5 (AUTHOR), Belaunzarán-Zamudio, Pablo F.5,7 (AUTHOR), Valdés-Ferrer, Sergio I.2,5,8 (AUTHOR) sergio.valdesf@incmnsz.mx |
| Source: | BMC Infectious Diseases. 10/16/2020, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712334 |
|---|---|
| DOI: | 10.1186/s12879-020-05485-7 |
